Mateon Therapeutics Inc (OTCQX US:MATN.PK)

0.221
Delayed Data
As of May 18
 +0.0149 / +7.23%
Today’s Change
0.09
Today|||52-Week Range
0.65
+50.44%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Loar Matthew M
Chief Financial Officer
Buy4/12/2018250,000$0.00$0.00-14.34%
Schwieterman William D
President & Chief Executive Officer
Buy4/12/2018625,000$0.00$0.00-14.34%
Reynolds Donald R
Director
Buy4/12/2018250,000$0.00$0.00-14.34%